Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...
Bristol Myers Squibb has forged close ties with China's Hengrui Pharma, partnering across 13 programmes in oncology, haematology, and immunology in a deal that could be worth a massive $15.2 billion.
Bristol Myers Squibb CEO Chris Boerner sits down with CNBC's Angelica Peebles at the American Society of Clinical Oncology's ...
Bristol Myers Squibb has formed a broad partnership with Hengrui Pharma, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines. The deal could be ...
Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal year 2026. Daiichi Sankyo aims to be a global top-5 oncology player ...
Summit said Harmoni-6 is the first Phase 3 study to show a "statistically significant" survival advantage over a PD-1 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...
Beth Dutton (Kelly Reilly) and Rip Wheeler (Cole Hauser) return in Taylor Sheridan's highly anticipated "Yellowstone" spinoff, "Dutton Ranch." The series will premiere with two episodes on Paramount+ ...
Ben Affleck and Matt Damon's Artists Equity negotiated a deal with the streamer for such a bonus, something that is not typical for Netflix. By Aaron Couch Film Editor “We built Artists Equity on the ...
Rip Rapson combines place-based philanthropy with cross-sector partnerships to forge creative solutions in American cities, leading the way in his backyard of Metro Detroit. The Kresge Foundation, ...
Two South Florida police officers sued Matt Damon and Ben Affleck's production company, claiming that the actors' recent action thriller, "The Rip," harmed their reputations. Jason Smith and Jonathan ...